Literature DB >> 21178961

Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays.

Pauline Chugh1, Kristen Tamburro, Dirk P Dittmer.   

Abstract

Quantitative real-time PCR (QPCR) has emerged as an accurate and valuable tool in profiling gene expression levels. One of its many advantages is a lower detection limit compared to other methods of gene expression profiling while using smaller amounts of input for each assay. Automated qPCR setup has improved this field by allowing for greater reproducibility. Its convenient and rapid setup allows for high-throughput experiments, enabling the profiling of many different genes simultaneously in each experiment. This method along with internal plate controls also reduces experimental variables common to other techniques. We recently developed a qPCR assay for profiling of pre-microRNAs (pre-miRNAs) using a set of 186 primer pairs. MicroRNAs have emerged as a novel class of small, non-coding RNAs with the ability to regulate many mRNA targets at the post-transcriptional level. These small RNAs are first transcribed by RNA polymerase II as a primary miRNA (pri-miRNA) transcript, which is then cleaved into the precursor miRNA (pre-miRNA). Pre-miRNAs are exported to the cytoplasm where Dicer cleaves the hairpin loop to yield mature miRNAs. Increases in miRNA levels can be observed at both the precursor and mature miRNA levels and profiling of both of these forms can be useful. There are several commercially available assays for mature miRNAs; however, their high cost may deter researchers from this profiling technique. Here, we discuss a cost-effective, reliable, SYBR-based qPCR method of profiling pre-miRNAs. Changes in pre-miRNA levels often reflect mature miRNA changes and can be a useful indicator of mature miRNA expression. However, simultaneous profiling of both pre-miRNAs and mature miRNAs may be optimal as they can contribute nonredundant information and provide insight into microRNA processing. Furthermore, the technique described here can be expanded to encompass the profiling of other library sets for specific pathways or pathogens.

Mesh:

Substances:

Year:  2010        PMID: 21178961      PMCID: PMC3155961          DOI: 10.3791/2210

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

2.  Automated processing of forensic casework samples using robotic workstations equipped with nondisposable tips: contamination prevention.

Authors:  Chantal J Frégeau; C Marc Lett; Jim Elliott; Craig Yensen; Ron M Fourney
Journal:  J Forensic Sci       Date:  2008-05       Impact factor: 1.832

3.  Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.

Authors:  Andrea J O'Hara; Pauline Chugh; Ling Wang; Eduardo M Netto; Estrella Luz; William J Harrington; Bruce J Dezube; Blossom Damania; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

  3 in total
  12 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 2.  miRNA analysis for the assessment of exercise and amino acid effects on human skeletal muscle.

Authors:  Stefan M Pasiakos; James P McClung
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 3.  Viral effects on the content and function of extracellular vesicles.

Authors:  Nancy Raab-Traub; Dirk P Dittmer
Journal:  Nat Rev Microbiol       Date:  2017-06-26       Impact factor: 60.633

4.  Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.

Authors:  Kristen M Tamburro; Dongmei Yang; Jessica Poisson; Yuri Fedoriw; Debasmita Roy; Amy Lucas; Sang-Hoon Sin; Nadia Malouf; Vincent Moylan; Blossom Damania; Stephan Moll; Charles van der Horst; Dirk P Dittmer
Journal:  Virology       Date:  2012-08-24       Impact factor: 3.616

5.  An important role for mitochondrial antiviral signaling protein in the Kaposi's sarcoma-associated herpesvirus life cycle.

Authors:  John A West; Megan Wicks; Sean M Gregory; Pauline Chugh; Sarah R Jacobs; Zhigang Zhang; Kurtis M Host; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

Review 6.  Potential pitfalls in microRNA profiling.

Authors:  Pauline Chugh; Dirk P Dittmer
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-05-07       Impact factor: 9.957

7.  The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Authors:  Amanda R Robinson; Swee Sen Kwek; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

8.  Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).

Authors:  Pauline E Chugh; Blossom A Damania; Dirk P Dittmer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

9.  Quantitation of microRNA-92a in colorectal adenocarcinoma and its precancerous lesions: Co-utilization of in situ hybridization and spectral imaging.

Authors:  I Weng Lao; Fengyun Cui; Hongguang Zhu
Journal:  Oncol Lett       Date:  2014-12-18       Impact factor: 2.967

10.  Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

Authors:  Pauline E Chugh; Sang-Hoon Sin; Sezgin Ozgur; David H Henry; Prema Menezes; Jack Griffith; Joseph J Eron; Blossom Damania; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.